MACBEATH GAVIN (Chief Scientific Officer) received a stock award from TSCAN THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/2/2026ACC: 0001193125-26-412521
Officer· Chief Scientific Officer
Since Jul 2021
+1M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1M acquired
Non-Derivative Transactions1
Voting Common Stock
Direct
Shares
+1M
Price / share
—
Trade value
—
% of position
2009.4%
10/1/2026
49.77K→1.05M
Total
Net shares
+1M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Direct | 10/1/2026 | A · Award | +1M | — | — | 2009.4% | 49.77K | 1.05M |
| Total | +1M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported